
Sign up to save your podcasts
Or


Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:
By Sequoia Capital4.2
3838 ratings
Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:

1,300 Listeners

539 Listeners

1,106 Listeners

2,347 Listeners

233 Listeners

210 Listeners

552 Listeners

143 Listeners

104 Listeners

682 Listeners

90 Listeners

476 Listeners

34 Listeners

41 Listeners

59 Listeners